Good morning :)
Place Order
Add to Watchlist

Gujarat Themis Biosyn Ltd

GUJTHEM Share Price

446.900.64% (-2.90)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹4,901 cr, stock is ranked 808

High Risk

Stock is 4.41x as volatile as Nifty

GUJTHEM Stock Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹4,901 cr, stock is ranked 808

High Risk

Stock is 4.41x as volatile as Nifty

GUJTHEM Performance & Key Metrics

GUJTHEM Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
101.4519.730.15%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.155.870.59%

GUJTHEM Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GUJTHEM Company Profile

The company makes bulk drugs. It's R&D division focuses on developing fermentation cultures. The Company's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Investor Presentation

View older View older 

Nov 10, 2025

PDF
View Older Presentations

GUJTHEM Similar Stocks (Peers)

Compare with peers Compare with peers 

GUJTHEM Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
38.57
38.57
1Y Return
0.63%
0.63%
Buy Reco %
91.43
91.43
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
67.85
67.85
1Y Return
23.51%
23.51%
Buy Reco %
76.92
76.92
Cipla Ltd
CIPLA
PE Ratio
23.47
23.47
1Y Return
2.16%
2.16%
Buy Reco %
67.74
67.74
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
18.34
18.34
1Y Return
1.57%
1.57%
Buy Reco %
41.94
41.94
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
21.00
21.00
1Y Return
1.35%
1.35%
Buy Reco %
50.00
50.00
Compare with Peers

GUJTHEM Forecast

GUJTHEM Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GUJTHEM

GUJTHEM

Income

Balance Sheet

Cash Flow

GUJTHEM Income Statement

GUJTHEM Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.92%, vs industry avg of 10.03%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.03% to 0.04%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 15.56%, vs industry avg of 20.02%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue36.0538.9743.2686.8293.83118.90154.98174.20152.48158.16
Raw Materialssubtract1.492.151.3015.4415.7521.7529.7325.6725.7885.71
Power & Fuel Costsubtract17.9919.3320.2022.8616.5721.7326.4126.5326.63
Employee Costsubtract4.424.465.176.437.117.087.7510.2111.44
Selling & Administrative Expensessubtract0.851.101.391.641.862.316.668.595.81
Operating & Other expensessubtract4.905.525.626.918.943.944.2020.1011.55
Depreciation/Amortizationsubtract1.121.151.221.361.732.232.583.545.377.78
Interest & Other Itemssubtract0.410.420.160.920.980.830.180.230.360.29
Taxes & Other Itemssubtract0.500.971.797.5910.7115.4119.5020.1816.7716.07
EPS0.400.360.592.172.774.005.325.434.484.43
DPS0.000.000.000.220.001.470.720.670.670.67
Payout ratio0.000.000.000.100.000.370.140.120.150.15
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

GUJTHEM Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Nov 10PDF
Aug 1PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 20PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Nov 15PDF
Nov 15PDF
Sep 13PDF
Sep 13PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

GUJTHEM Stock Peers

GUJTHEM Past Performance & Peer Comparison

GUJTHEM Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Gujarat Themis Biosyn Ltd100.5019.730.15%
Sun Pharmaceutical Industries Ltd38.575.820.91%
Torrent Pharmaceuticals Ltd67.8517.080.84%
Cipla Ltd23.473.961.04%

GUJTHEM Stock Price Comparison

Compare GUJTHEM with any stock or ETF
Compare GUJTHEM with any stock or ETF
GUJTHEM
Loading...

GUJTHEM Holdings

GUJTHEM Shareholdings

GUJTHEM Promoter Holdings Trend

GUJTHEM Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GUJTHEM Institutional Holdings Trend

GUJTHEM Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GUJTHEM Shareholding Pattern

GUJTHEM Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.86%1.16%0.01%2.95%25.01%

Feb 2025

Mar 2025

Jun 2025

Sep 2025

GUJTHEM Shareholding History

GUJTHEM Shareholding History

SepDec '24FebMarJunSep1.49%1.42%1.48%1.91%2.51%2.95%

Mutual Funds Invested in GUJTHEM

Mutual Funds Invested in GUJTHEM

No mutual funds holding trends are available

Top 3 Mutual Funds holding Gujarat Themis Biosyn Ltd

Funds (Top 3)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
quant Manufacturing Fund - Growth Option - Direct Plan

Growth
0.9451%5.89%1.15%19/46 (0)
Quant Value Fund - Direct Plan Growth Growth

Growth
0.2448%0.69%0.12%26/52 (-4)
Bandhan BSE Healthcare Index Fund Direct Plan-Growth

Growth
0.0004%0.11%0.02%76/124 (+3)

Compare 3-month MF holding change on Screener

GUJTHEM Insider Trades & Bulk Stock Deals

GUJTHEM Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing GUJTHEM stock

smallcases containing GUJTHEM stock

Looks like this stock is not in any smallcase yet.

GUJTHEM Events

GUJTHEM Events

GUJTHEM Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

GUJTHEM Dividend Trend

No dividend trend available

GUJTHEM Upcoming Dividends

GUJTHEM Upcoming Dividends

No upcoming dividends are available

GUJTHEM Past Dividends

GUJTHEM Past Dividends

Cash Dividend

Ex DateEx DateSep 4, 2025

Final
Final | Div/Share: ₹0.67

Dividend/Share

₹0.67

Ex DateEx Date

Sep 4, 2025

Cash Dividend

Ex DateEx DateJul 15, 2024

Final
Final | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Jul 15, 2024

Cash Dividend

Ex DateEx DateFeb 22, 2024

Interim
Interim | Div/Share: ₹0.75

Dividend/Share

₹0.75

Ex DateEx Date

Feb 22, 2024

Cash Dividend

Ex DateEx DateSep 1, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 1, 2023

Cash Dividend

Ex DateEx DateDec 1, 2022

Interim
Interim | Div/Share: ₹4.40

Dividend/Share

₹4.40

Ex DateEx Date

Dec 1, 2022

GUJTHEM Stock News & Opinions

GUJTHEM Stock News & Opinions

Earnings
Gujarat Themis Biosyn standalone net profit rises 34.91% in the September 2025 quarter

Net profit of Gujarat Themis Biosyn rose 34.91% to Rs 14.26 crore in the quarter ended September 2025 as against Rs 10.57 crore during the previous quarter ended September 2024. Sales rose 21.98% to Rs 42.35 crore in the quarter ended September 2025 as against Rs 34.72 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales42.3534.72 22 OPM %49.4244.35 - PBDT21.7115.64 39 PBT18.7514.20 32 NP14.2610.57 35 Powered by Capital Market - Live

5 days agoCapital Market - Live
Corporate
Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live

1 week agoCapital Market - Live
Corporate
Gujarat Themis Biosyn AGM scheduled

Gujarat Themis Biosyn announced that the Annual General Meeting(AGM) of the company will be held on 12 September 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Gujarat Themis Biosyn standalone net profit declines 31.57% in the June 2025 quarter

Net profit of Gujarat Themis Biosyn declined 31.57% to Rs 9.06 crore in the quarter ended June 2025 as against Rs 13.24 crore during the previous quarter ended June 2024. Sales declined 7.62% to Rs 35.87 crore in the quarter ended June 2025 as against Rs 38.83 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales35.8738.83 -8 OPM %38.8147.80 - PBDT14.1519.01 -26 PBT12.1217.86 -32 NP9.0613.24 -32 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Gujarat Themis Biosyn to announce Quarterly Result

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 1 August 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Board of Gujarat Themis Biosyn recommends final dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting held on 20 May 2025, inter alia, have recommended the final dividend of Rs 0.67 per equity Share (i.e. 67%) , subject to the approval of the shareholders.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Gujarat Themis Biosyn standalone net profit declines 24.48% in the March 2025 quarter

Net profit of Gujarat Themis Biosyn declined 24.48% to Rs 12.00 crore in the quarter ended March 2025 as against Rs 15.89 crore during the previous quarter ended March 2024. Sales declined 10.16% to Rs 37.74 crore in the quarter ended March 2025 as against Rs 42.01 crore during the previous quarter ended March 2024. For the full year,net profit declined 17.56% to Rs 48.77 crore in the year ended March 2025 as against Rs 59.16 crore during the previous year ended March 2024. Sales declined 11.20% to Rs 150.80 crore in the year ended March 2025 as against Rs 169.82 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales37.7442.01 -10 150.80169.82 -11 OPM %42.5049.82 -45.6546.37 - PBDT17.3221.88 -21 70.9182.88 -14 PBT16.0920.96 -23 65.5479.34 -17 NP12.0015.89 -24 48.7759.16 -18 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Gujarat Themis Biosyn to announce Quarterly Result

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 20 May 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Gujarat Themis Biosyn standalone net profit declines 0.31% in the December 2024 quarter

Net profit of Gujarat Themis Biosyn declined 0.31% to Rs 12.97 crore in the quarter ended December 2024 as against Rs 13.01 crore during the previous quarter ended December 2023. Sales rose 1.91% to Rs 39.52 crore in the quarter ended December 2024 as against Rs 38.78 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales39.5238.78 2 OPM %47.7245.56 - PBDT18.9618.67 2 PBT17.4017.69 -2 NP12.9713.01 0 Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Gujarat Themis Biosyn Ltd (GUJTHEM) today?

    The share price of GUJTHEM as on 14th November 2025 is ₹446.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Gujarat Themis Biosyn Ltd (GUJTHEM) share?

    The past returns of Gujarat Themis Biosyn Ltd (GUJTHEM) share are
    • Past 1 week: 0.92%
    • Past 1 month: 7.61%
    • Past 3 months: 26.06%
    • Past 6 months: 41.81%
    • Past 1 year: 51.96%
    • Past 3 years: 294.95%
    • Past 5 years: 1072.97%

  3. What are the peers or stocks similar to Gujarat Themis Biosyn Ltd (GUJTHEM)?

    The peers or stocks similar to Gujarat Themis Biosyn Ltd (GUJTHEM) include:

  4. What is the dividend yield % of Gujarat Themis Biosyn Ltd (GUJTHEM) share?

    The current dividend yield of Gujarat Themis Biosyn Ltd (GUJTHEM) is 0.15.

  5. What is the market cap of Gujarat Themis Biosyn Ltd (GUJTHEM) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Themis Biosyn Ltd (GUJTHEM) is ₹4901.26 Cr as of 14th November 2025.

  6. What is the 52 week high and low of Gujarat Themis Biosyn Ltd (GUJTHEM) share?

    The 52-week high of Gujarat Themis Biosyn Ltd (GUJTHEM) is ₹479 and the 52-week low is ₹192.35.

  7. What is the PE and PB ratio of Gujarat Themis Biosyn Ltd (GUJTHEM) stock?

    The P/E (price-to-earnings) ratio of Gujarat Themis Biosyn Ltd (GUJTHEM) is 100.50. The P/B (price-to-book) ratio is 19.73.

  8. Which sector does Gujarat Themis Biosyn Ltd (GUJTHEM) belong to?

    Gujarat Themis Biosyn Ltd (GUJTHEM) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Gujarat Themis Biosyn Ltd (GUJTHEM) shares?

    You can directly buy Gujarat Themis Biosyn Ltd (GUJTHEM) shares on Tickertape. Simply sign up, connect your demat account and place your order.